DMAC DiaMedica Therapeutics Inc.

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Latest News

1. 19 March 2019 DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update
2. 18 March 2019 DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call
3. 12 March 2019 DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019
4. 14 February 2019 DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease
5. 22 January 2019 DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders
6. 16 January 2019 OTC Markets Group Announces Quarterly Index Performance and Rebalancing
7. 10 January 2019 The Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO Quits
8. 09 January 2019 DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange
9. 03 January 2019 UPDATE - DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease
10. 02 December 2018 IPO Outlook For The Week: Proteins, Fashion And Finance